Katerina Tiligada
Overview
Explore the profile of Katerina Tiligada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bruscoli S, Puzzovio P, Zaimi M, Tiligada K, Levi-Schaffer F, Riccardi C
Pharmacol Res
. 2022 Oct;
185:106511.
PMID: 36243331
Coronavirus Disease 19 (COVID-19) is associated with high morbidity and mortality rates globally, representing the greatest health and economic challenge today. Several drugs are currently approved for the treatment of...
2.
Sioutas G, Minoudi S, Tiligada K, Chliva C, Triantafyllidis A, Papadopoulos E
Pathogens
. 2021 Apr;
10(3).
PMID: 33806588
(the poultry red mite, PRM) is an important ectoparasite in the laying hen industry. PRM can also infest humans, causing gamasoidosis, which is manifested as skin lesions characterized by rash...
3.
Ennis M, Tiligada K
Inflamm Res
. 2020 Nov;
70(1):67-75.
PMID: 33206207
Objective: Reports that the over-the-counter histamine H receptor antagonist famotidine could help treat the novel coronavirus disease (COVID-19) appeared from April 2020. We, therefore, examined reports on interactions between severe...
4.
Veglia E, Pini A, Moggio A, Grange C, Premoselli F, Miglio G, et al.
Pharmacol Res
. 2016 Nov;
114:27-38.
PMID: 27751877
Histamine has been reported to decrease the ultrafiltration coefficient, which inversely correlates with glomerular permselectivity, however the mechanism(s) underling this effect have never been investigated. This study aimed to assess...